Search results for "Claudication"

showing 10 items of 47 documents

Sensory neuropathy and signs of central sensitization in patients with peripheral arterial disease.

2006

Patients with peripheral arterial disease (PAD) may develop a broad range of peripheral nerve dysfunctions including pain and sensory deficiencies due to chronic ischemia mostly involving the lower limbs. To investigate the degree of sensory abnormalities in such patients quantitative sensory testing (QST) might be a useful tool. Forty-five patients and 20 controls were enrolled in the present study and underwent QST according to the protocol of the German Research Network on Neuropathic Pain. PAD was graded according to the Rutherford classification. PAD patients were divided into two groups: 16 patients with critical limb ischemia (severe PAD) and 29 patients with intermittent claudicatio…

MalePain ThresholdIschemiaSensationSensationmedicineHumansThermosensingAgedPain MeasurementNeurologic ExaminationPeripheral Vascular DiseasesAnalysis of Variancebusiness.industryPeripheral Nervous System DiseasesCritical limb ischemiamedicine.diseaseIntermittent claudicationbody regionsAnesthesiology and Pain MedicinePeripheral neuropathyAllodyniamedicine.anatomical_structureNeurologyAnesthesiaCase-Control StudiesNeuropathic painSensation DisordersFemaleNeurology (clinical)medicine.symptombusinessSensory nervePain
researchProduct

One simple claudication question as first step in Peripheral Arterial Disease (PAD) screening: A meta-analysis of the association with reduced Ankle …

2019

Purpose and methods A meta-analysis using data from seven German population-based cohorts was performed by the German Epidemiological consortium of Peripheral Arterial Disease (GEPArD) to investigate whether one question about claudication is more efficient for PAD screening than established questionnaires. Claudication was defined on the basis of the answer to one question asking for pain in the leg during normal walking. This simple question was compared with established questionnaires, including the Edinburgh questionnaire. The associations of claudication with continuous ABI values and decreased ABI were analyzed by linear and logistic regression analysis, respectively. The results of t…

MaleQuestionnairesMedical DoctorsPhysiologyHealth Care ProvidersMedizinWalking030204 cardiovascular system & hematologyLogistic regressionVascular MedicineMathematical and Statistical TechniquesEndocrinology0302 clinical medicineSurveys and QuestionnairesEpidemiologyMedicine and Health SciencesMass ScreeningMedicineMedical Personnel030212 general & internal medicineMultidisciplinaryStatisticsQRMetaanalysisProfessionsmedicine.anatomical_structureResearch DesignMeta-analysisPhysical SciencesMedicineFemalemedicine.symptomResearch Articlemedicine.medical_specialtySilverEndocrine DisordersDeath RatesScienceResearch and Analysis MethodsSensitivity and SpecificityOddsPeripheral Arterial Disease03 medical and health sciencesSex FactorsPopulation MetricsGeneral PractitionersPhysiciansDiabetes mellitusInternal medicineDiabetes MellitusHumansAnkle Brachial IndexVascular Diseasesddc:610Statistical MethodsSurvey ResearchPopulation BiologyBiological Locomotionbusiness.industryBiology and Life SciencesOdds ratioIntermittent Claudicationmedicine.diseaseHealth CarePeripheral Vascular DiseaseMetabolic DisordersPeople and PlacesPopulation GroupingsAnklebusinessClaudicationMathematics
researchProduct

Psychometric Assessment of the Japanese Version of the Zurich Claudication Questionnaire (ZCQ): Reliability and Validity.

2016

Purpose The Zurich Claudication Questionnaire (ZCQ) is a self-administered measure to evaluate symptom severity, physical function, and surgery satisfaction in lumbar spinal stenosis (LSS). The purpose of this study is to assess the psychometric properties of the Japanese ZCQ in LSS patients. Methods LSS patients who are scheduled to undergo surgery were recruited from 12 facilities. Responses to several questionnaires, including the Japanese ZCQ; the visual analogue scale (VAS) to evaluate the degree of pain in the buttocks/legs, numbness in the buttocks/legs, and low back pain; the Oswestry Disability Index (ODI); and the SF-36v2, were collected before surgery and again 3 months after sur…

MaleQuestionnairesResearch ValidityPsychometricsSocial Scienceslcsh:MedicinePathology and Laboratory Medicine0302 clinical medicineSpinal StenosisJapanSurveys and QuestionnairesMedicine and Health SciencesPsychology030212 general & internal medicinelcsh:ScienceMusculoskeletal SystemStenosisMultidisciplinaryLumbar VertebraeMiddle AgedResearch AssessmentLow back painOswestry Disability IndexPatient SatisfactionResearch DesignLegsFemalemedicine.symptomAnatomyResearch Articlemedicine.medical_specialtyPsychometricsVisual analogue scaleConcurrent validityLower Back PainPainSurgical and Invasive Medical ProceduresResearch and Analysis Methods03 medical and health sciencesPatient satisfactionPhysical medicine and rehabilitationSigns and SymptomsCronbach's alphaDiagnostic MedicineMental Health and PsychiatrymedicineHumansAgedSurvey Researchbusiness.industryLimbs (Anatomy)lcsh:RBiology and Life SciencesPhysical therapylcsh:QbusinessClaudication030217 neurology & neurosurgeryPLoS ONE
researchProduct

Contemporary results with the biosynthetic glutaraldehyde denatured ovine collagen graft (Omniflow II) in femoropopliteal position

2020

Abstract Objective The objective of this study was to analyze the outcome of a contemporary series of femoropopliteal bypass operations with the glutaraldehyde denatured polyester mesh-reinforced ovine collagen prosthesis (OCP; Omniflow II [LeMaitre Vascular, Inc, Burlington, Mass]). The experience of two tertiary centers regarding long-term graft function, secondary reinterventions, and biodegeneration of the OCP prosthesis is presented. Methods Between January 2006 and January 2014, a series of 205 consecutive operations with the OCP in the femoropopliteal position (54 above knee and 151 below knee) were performed in 194 patients in 202 limbs for disabling claudication (72), chronic criti…

MaleReoperationmedicine.medical_specialtyPolyestersmedicine.medical_treatmentIschemia030204 cardiovascular system & hematologyProsthesisBlood Vessel Prosthesis Implantation03 medical and health sciencesPostoperative Complications0302 clinical medicineAneurysmBlood vessel prosthesisOcclusionmedicineAnimalsHumansVascular PatencyPopliteal Artery030212 general & internal medicineSheep DomesticVascular PatencyAgedRetrospective StudiesAged 80 and overBioprosthesisPeripheral Vascular Diseasesmedicine.diagnostic_testbusiness.industryAngiographyMiddle AgedSurgical MeshLimb Salvagemedicine.diseaseBlood Vessel ProsthesisSurgeryFemoral ArteryGlutaralAngiographyFemaleSurgeryCollagenmedicine.symptomCardiology and Cardiovascular MedicineClaudicationbusinessJournal of Vascular Surgery
researchProduct

Pharmacological treatment of patients with chronic critical limb ischemia: L-propionyl-carnitine enhances the short-term effects of PGE-1.

2009

Purpose. To evaluate the therapeutic effects of L-propionyl-carnitine (LPC) in patients with critical limb ischemia (CLI), as defined by the TASC guidelines. Methods. The study, double-blinded, randomised, assessed intravenous infusion of LPC 1.2 g/day in combination with PGE-1, 60 mg/day (LPC group: 37 patients), or PGE-1 only (control group: 38 patients) in a total of 75 patients suffering from CLI. Treatment duration was 20 days. We evaluated rest pain, maximum walking distance (MWD) and skin ulcer size. Results. In both groups we observed a significant reduction in pain score and ulcer size and an increase in MWD. In the patients treated with the combination, the improvement was greater…

MaleSettore MED/09 - Medicina InternaCardiotonic AgentsVasodilator AgentsProstaglandin E1IschemiaPainWalkinglaw.inventionchemistry.chemical_compoundRandomized controlled trialDouble-Blind MethodlawIschemiaCarnitinemedicineHumansPharmacology (medical)CarnitineAlprostadilProstaglandin E1Infusions IntravenousAgedPharmacologyLegCritical Limb Ischemiabusiness.industryTherapeutic effectLeg UlcerDrug SynergismGeneral MedicineCritical limb ischemiaL-PropionylcarnitineSkin ulcerMiddle Agedmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareTreatment OutcomechemistryAnesthesiaChronic Diseaselipids (amino acids peptides and proteins)Drug Therapy CombinationFemalemedicine.symptomCardiology and Cardiovascular MedicineClaudicationbusinessmedicine.drugCardiovascular drugs and therapy
researchProduct

Efficacy and one-year outcomes of Luminor® paclitaxel-coated drug-eluting balloon in the treatment of popliteal artery atherosclerosis lesions

2021

Purpose: Reporting outcomes with a new generation paclitaxel eluting balloon (Luminor®; iVascular, Vascular, S.L.U., Barcelona, Spain) in the popliteal district. Endovascular treatment of popliteal artery atherosclerotic disease is still debated without definitive evidences. Methods: From January to June 2019, patients’ data presenting popliteal artery atherosclerotic diseases and treated with the Luminor® (iVascular) drug eluting balloon (DEB) were prospectively collected. Critical limb ischemia (CLI) or severe claudication associated with popliteal artery stenosis >50% were the inclusion criteria. Measured outcomes were technical success, early and late results; including mortality, mo…

MaleTime Factorsmedicine.medical_treatmentConstriction Pathologic030204 cardiovascular system & hematologySeverity of Illness IndexSettore MED/22 - Chirurgia Vascolare030218 nuclear medicine & medical imaging0302 clinical medicineRestenosisCoated Materials BiocompatibleIschemiaRecurrenceMedicineProspective StudiesAged 80 and overEndovascularCritical limb ischemiaGeneral MedicineEquipment DesignLimb SalvagePlaque AtheroscleroticTreatment OutcomeFemalemedicine.symptomCardiology and Cardiovascular MedicineVascular Access Devicesmedicine.medical_specialtyPaclitaxelPopliteal arteryCritical IllnessDrug eluting balloonAmputation Surgical03 medical and health sciencesPeripheral Arterial Diseasemedicine.arteryAngioplastyHumansVascular PatencyAgedbusiness.industryAngioplastyCardiovascular AgentsCritical limb ischemiaPerioperativeIntermittent Claudicationmedicine.diseasePopliteal arterySurgeryStenosisAmputationSurgerybusinessClaudicationAngioplasty Balloon
researchProduct

Initial experience with a new method of external polyester scaffolding for infrainguinal vein grafts.

2009

Abstract Objectives This study aims to evaluate the feasibility of external polyester scaffolding in infrainguinal bypass grafting when available vein material is suboptimal due to varicosity or dilatation. Primary objectives were short-term primary patency, assisted primary patency and secondary patency. Secondary objectives were to assess the rate of graft stenoses, infections and other adverse effects related to the use of external scaffolding. Materials and methods A total of 50 consecutive patients were included in this prospective, multicentre, feasibility study from six centres. The indication for infrainguinal bypass was critical limb ischaemia (64%), severe claudication (34%) or po…

MaleTime Factorsmedicine.medical_treatmentPilot ProjectsKaplan-Meier EstimateIschemiaMedicinePopliteal ArteryProspective StudiesExternal polyester mesh supportMedicine(all)Aged 80 and overPeripheral Vascular DiseasesUltrasonography Doppler DuplexGraft Occlusion VascularEquipment DesignMiddle Agedmedicine.anatomical_structureTreatment OutcomeLower ExtremityFemaleRadiologymedicine.symptomCardiology and Cardiovascular MedicineVascular Surgical ProceduresInfrainguinal bypassAdultReoperationmedicine.medical_specialtyInfrainguinal bypassPolyestersVein graftRevascularizationVeinsPopliteal aneurysmDuplex scanningEctasiaHumansSurgical Wound InfectionVeinVascular PatencyAgedbusiness.industryPhlebographyIntermittent ClaudicationSurgical MeshVein graftAneurysmSurgeryFeasibility StudiesSurgerybusinessClaudicationEuropean journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
researchProduct

Outcomes of complex femorodistal sequential autologous vein and biologic prosthesis composite bypass grafts

2014

Objective Femorodistal autologous vein bypass proves to be the preferred surgical therapy for long arterial occlusions and provides excellent early and long-term results in critical lower limb ischemia. Whenever vein length was insufficient and two distal outflow arteries were present, a sequential composite bypass configuration was chosen with human umbilical vein (HUV) or ovine collagen prosthesis (Omniflow II; Bio Nova International Pty Ltd, North Melbourne, Australia) as the proximal prosthetic part of the bypass. Single-center experience with this technique regarding limb salvage, graft function, secondary reinterventions, and biodegeneration is presented. Methods Between January 1998 …

MaleUmbilical Veinsmedicine.medical_specialtyTime Factorsmedicine.medical_treatmentIschemiaProsthesis DesignProsthesisBlood Vessel Prosthesis ImplantationPeripheral Arterial DiseaseRisk FactorsBlood vessel prosthesismedicineAnimalsHumansVascular PatencyAutograftsVascular PatencyAgedRetrospective StudiesAged 80 and overBioprosthesisUltrasonography Doppler DuplexSheepmedicine.diagnostic_testbusiness.industryRetrospective cohort studyMiddle AgedLimb Salvagemedicine.diseaseThrombosisBlood Vessel ProsthesisSurgeryFemoral ArteryRadiographyTreatment OutcomeAngiographyHeterograftsFemaleSurgerymedicine.symptomCardiology and Cardiovascular MedicineClaudicationbusinessJournal of Vascular Surgery
researchProduct

Women and peripheral arterial disease: same disease, different issues

2008

Objectives Atherosclerosis is a multifactorial disease and, thus, its clinical manifestations are likely to present gender-specific differences with respect to their development, course, symptom complexes and prognosis. The present study aimed to examine sex differences in peripheral arterial disease (PAD) and its clinical correlates. Methods PAD severity, quality of life (assessed by ST-22), cardiovascular risk factors, inflammatory profile and comorbidity were assessed in 163 men and 68 women who were consecutively diagnosed with PAD at three Italian University vascular centres. Results Compared to men, women showed a higher prevalence of critical limb ischemia (P = 0.018), but had a less…

Malemedicine.medical_specialtyArterial diseaseDiseaseComorbiditySeverity of Illness IndexStatistics NonparametricQuality of lifeperipheral arterial diseaseRisk FactorsInternal medicineSeverity of illnessgenderPrevalenceMedicineHumansSex DistributionInflammationPeripheral Vascular DiseasesLegChi-Square Distributionbusiness.industryMultifactorial diseaseCritical limb ischemiaintermittent claudicationGeneral Medicinemedicine.diseaseAtherosclerosisComorbidityPeripheralLogistic ModelsItalyQuality of LifeFemaleCardiology and Cardiovascular MedicinebusinessChi-squared distribution
researchProduct

Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease

2006

The type of dyslipidemia in patients with peripheral arterial disease (PAD) is still ill defined. PAD patients often show elevated triglycerides and reduced HDL-cholesterol, two lipid abnormalities usually accompanied by decreased LDL size in the "atherogenic lipoprotein phenotype" (ALP). We investigated (1) whether PAD patients have lower LDL size, (2) altered LDL subclass distribution and (3) the prevalence of ALP. We measured plasma lipids and LDL size and subclasses by gradient gel electrophoresis in 31 adults with intermittent claudication and 31 age-BMI-matched controls. Patients had higher prevalence of hypertension (p = .0132), smoking (p < .0020) and diabetes (p = .0024), with lowe…

Malemedicine.medical_specialtyAtherogenic lipoprotein phenotypeLDL sizeTriglyceridechemistry.chemical_compoundRisk FactorsInternal medicineDiabetes mellitusPeripheral arterial diseaseMedicineHumansRisk factorParticle SizeTriglyceridesAgedDyslipidemiasPeripheral Vascular DiseasesTriglyceridebusiness.industryVascular diseaseCholesterolCholesterol HDLCholesterol LDLMiddle Agedmedicine.diseaseAtherosclerosisIntermittent claudicationHDL-cholesterolEndocrinologyPhenotypechemistrylipids (amino acids peptides and proteins)medicine.symptomCardiology and Cardiovascular MedicinebusinessDyslipidemiaLipoprotein
researchProduct